Russian opposition activist Alexei Navalny arrested on arrival as he returns home
LONG READ: The oligarch problem
COVID-19 and Trump’s indifference helped human rights abusers in 2020
Durov rejects Western funds’ offer to buy 5%-10% of Telegram with $30bn valuation
One of Russia’s biggest wood product companies, Segezha could be Sistema’s next IPO
New Ukrainian VC firm QPDigital aims to invest up to $100 million in digital startups
EBRD investments reach record €11bn in pandemic-struck 2020
OUTLOOK 2021 Lithuania
EBRD says loan to Estonia’s controversial Porto Franco project was never disbursed
Estonian premier quits after Tallinn development scandal
Czech Pirates and Mayors approve final coalition agreement for 2021 elections
OUTLOOK 2021 Czechia
BRICKS & MORTAR: Rosier future beckons for CEE retailers after year of change and disruption
OUTLOOK 2021 Hungary
Hungarian government remains silent after Capitol riots
World Bank expects modest recovery for Europe and Central Asia in 2021
OUTLOOK 2021 Slovakia
FDI inflows to CEE down 58% in 1H20 but rebound expected
Slovakia to invest €1.2bn in digitisation
BALKAN BLOG: The controversial recipe for building up Albania
Heavy flooding causes chaos in parts of Southeast Europe
Vodafone Albania plans €100mn infrastructure investments after AbCom merger
OUTLOOK 2021 Albania
Turnover rose on Bosnia's two stock exchanges in 2020 while prices fell
Storming parliaments: New Europe's greatest hits
Kyiv accuses Bosnian President Dodik of lying about icon gifted to Russian foreign minister
Sofia-based LAUNCHub Ventures holds first close of new fund on €44mn
ING THINK: Growth in the Balkans: from zero to hero again?
OUTLOOK 2020 Bulgaria
Labour demand down 28% y/y in Croatia in 2020
Zagreb Stock Exchange's Crobex10 index at highest level since March 5
OUTLOOK 2021 Kosovo
Arrera Automobili aims to launch Albania’s first supercar
World Bank revises projection for Moldova’s 2020 GDP decline to 7.2%
Moldova’s PM resigns to prepare the ground for early elections
Socialist lawmakers in Moldova scrap settlement on $1bn bank frauds
75% of Montenegrins want EU membership
Montenegro’s new ruling coalition carves up top state jobs
OUTLOOK 2021 Montenegro
North Macedonia's manufacturing confidence indicator down by 8.5 pp y/y in December
OUTLOOK 2021 North Macedonia
Transparency International warns of high corruption risk in CEE defence sectors
OUTLOOK 2021 Romania
Romania’s central bank cuts monetary policy rate by 25bp to 1.25%
Romanian construction companies' activity slows in November after intense 2020
OUTLOOK 2021 Serbia
Slovenia’s opposition files no-confidence motion against Jansa cabinet
Slovenia’s government to release funds to news agency STA after EU pressure
UK Moneyhub picks Slovenia for post-Brexit European base
Slovenia’s dire COVID-19 situation in 4Q20 caused second economic dip
Turkcell denies any affiliation with $1.6bn loan in default extended by Ziraat Bank to Virgin Islands company
BEYOND THE BOSPORUS: Let’s tentatively pencil in a date for Turkey’s hot money outflow
OUTLOOK 2021 Armenia
Armenia’s PM cautions conflict with Azerbaijan “still not settled” after trilateral meeting with Putin
COMMENT: Record high debt levels will slow post-coronavirus recovery, threaten some countries' financial stability, says IIF
OUTLOOK 2021 Georgia
Georgia’s political kingpin Bidzina Ivanishvili quits politics
Modern-day “Robin Hood” inspires Georgians drowning in debt
Iran’s navy conducts missile drill while analyst argues Trump even capable of nuclear strike in final days
TEHRAN BLOG: Who’s more credible? Johnson backing Trump’s Nobel chances or Iran applauding arrest warrant for US president?
Central Asia vaccination plans underwhelm, but governments look unruffled
Fears of authoritarianism as Kyrgyz populist wins landslide and backing for ‘Khanstitution’
OUTLOOK 2021 Kyrgyzstan
Mongolia's winter dzud set to be one of most extreme on record says Red Cross
Mongolian coal exports to China paralysed as Beijing demands virus testing of truck drivers
Mongolia fears economic damage as country faces up to its first local transmissions of coronavirus
Mongolia in lockdown after suffering first local coronavirus transmissions
OUTLOOK 2021 Tajikistan
China business briefing: Not happy with Kyrgyzstan
OUTLOOK 2021 Turkmenistan
Turkmenistan: How the Grinch stole New Year
Turkmenistan: The dammed united
COMMENT: Uzbekistan is being transformed, but where are the democratic reforms?
OUTLOOK 2021 Uzbekistan
Download the pdf version
Russia will start mass vaccinations of its population on December 7, Russian President Vladimir Putin said on December 3.
Putin ordered Deputy Prime Minister Tatyana Golikova to begin mass vaccinations, adding that more than 2mn doses are already available for distribution or can be ready in several days.
“Mass vaccinations should have a limited impact on our growth expectations, but they should ease concerns about stricter lockdowns in 4Q20 and 1Q21,” Sova Capital said in a note. “We think the epidemiological situation could drag down economic activity from a contraction of 3.6% year on year in 3Q20 to a deeper contraction of 4% y/y in 4Q20. We keep our 2021 GDP growth forecast at 2.8% y/y.”
Vaccinations will be voluntary and free of charge for Russian citizens, with teachers and doctors the priority, assuming they agree to be vaccinated.
Earlier, analysts estimated that provided there was sufficient supply of the Sputnik V vaccine, Russia’s entire population of over-65 year-olds could be vaccinated within two months. A mass vaccination should lead to a rapid fall in infection rates that have been running at record levels of over 25,000 a day in the last month.
Mass vaccinations have already started in the army. According to Minister of Defence Sergei Shoygu, 80,000 soldiers and officers will be vaccinated by the end of this year (2,500 have already been vaccinated). Overall, the ministry plans to vaccinate 400,000 members of Russia's armed forces.
President Vladimir Putin ordered Deputy Prime Minister Tatyana Golikova, who is in charge of the social sphere, to begin mass vaccinations from December 7
The Gamaleya Research Institute of Epidemiology and Microbiology that developed the vaccine reported that the interim results of the third phase of testing showed its vaccine to be 92% effective. Side-effects were seen in 15% of participants during the clinical trials, according to Alexander Gintsburg, the institute’s director.
Two Russian vaccines have already been registered (Sputnik V and EpiVacCorona from Vektor), and another one is preparing for the third phase of clinical trials.
According to The Bell, the first foreign vaccines that could reach the Russian market are from CanSino Bio and AstraZeneca, which will be produced in Russia under licence. Russia has been participating in the trials of these vaccines, and local pharmaceutical companies have agreed to localise their production.
“Mass vaccinations should have a limited impact on our growth expectations, but they should ease concerns about stricter lockdowns in 4Q20 and 1Q21. On the one hand, it is unclear whether production capacities are enough to cover the desired volumes next year; on the other hand, Russians are concerned about the efficiency of the Sputnik V vaccine and its possible side-effects,” Sova Capital said.
According to a VTsIOM poll conducted in August, 52% of respondents do not want to receive the Sputnik V vaccine. Online polls in October conducted by Superjob and United Russia found that 44% to 73% of respondents do not want to be vaccinated at all. “It may be some time before the general public is open to receiving a vaccine,” Sova said.
Russia has been suffering from a second wave of coroanvirus (COVID-19) since September, with the number of new cases reaching 27,000 per day by the end of November. The number of new cases has gradually dropped over the past week from 27,543 per day to 25,345 per day as of yesterday, December 2. Leading indicators, such as a keyword search in Yandex, point to the peak having passed, but they do not suggest that the second wave is anywhere near over.
Most regional authorities have avoided imposing strict lockdowns during the second wave. As a result, hospital capacities were 78% full on average in Russia as of the end of November. In comparison, hospital capacities in 43 regions are above the nationwide average, with hospital capacities in six regions at more than 90%, according to Deputy Prime Minister Tatyana Golikova. The death toll has quintupled since September, with 589 deaths reported yesterday, the highest single-day number yet. The overall death toll in Russia from COVID-19 is now 41,000.
“With the introduction of vaccines, authorities are unlikely to impose stricter measures in 2021 either nationally or regionally, although they could extend the existing ones. We think the epidemiological situation could drag down economic activity from a contraction of 3.6% y/y in 3Q20 to a deeper contraction of 4% y/y in 4Q20. We keep our 2021 GDP growth forecast at 2.8% y/y,” Sova concluded.
Production delays make roll-out less likely
All of these forecasts are overly optimistic, according to The Bell. Putin spoke today about 2mn doses “in the coming days.” Tatyana Golikova on November 24 called the same figure, but already "until the end of 2020". The Bell source familiar with the process says that no more than 500,000 doses will be ready by the end of the year.
A source at one of the companies working on the vaccine told The Bell today that "it is clear that the number of vaccines that will be available in winter is too small to vaccinate the required population."
So far, as Golikova said on November 24, 117,000 Russians have received the vaccine (including within the framework of the so-called "post-registration tests").
At the beginning of November, the drug began to be supplied to the regions, but so far in microscopic doses. At the end of November, RBC collected reports from large regions (Tatarstan, Perm Territory, Bashkiria), which called the same numbers: 84 doses needed to vaccinate 42 people. The Governor of St Petersburg, Alexander Beglov, said that 400 doses were received in St Petersburg, and 4,667 doses should be received by the end of the year. Moscow did not disclose similar numbers.
The problem is the scaling up of vaccine production at the facilities of the four pharmaceutical companies that are producing it. In early November, The Bell wrote that none of the manufacturers could produce a stable drug, which means that they cannot yet produce it in a large batch.
One of The Bell's sources is confident that the real mass vaccination will not begin until mid-late spring. A source close to the government assures that this will happen "before spring", but only after "it is clear that there will be no disruptions from the start of the vaccination, it will gradually go across the country."
here to continue reading this article
and 5 more for free or purchase
12 months full website access including
the bne Magazine for just $250/year.
Register to read the bne monthly magazine for
Password could contain only
and have 8-20 symbols length.
Please complete your registration by confirming your
A confirmation email has been sent to the email
address you provided.
can't be empty.
No user with
this email address.
Access recovery request has expired, or you are using
the wrong recovery token. Please, try again.
Access recover request has expired.
Please, try again.
To continue viewing our content you need to complete
the registration process.
Please look for an email that was sent to
with the subject line
"Confirmation bne IntelliNews access". This email will have
instructions on how to complete registration
process. Please check in your "Junk" folder in
case this communication was misdirected in your
If you have any questions please contact us at firstname.lastname@example.org
Sorry, but you have used all your free articles fro
this month for bne IntelliNews. Subscribe
to continue reading for only $119 per year.
Your subscription includes:
For the meantime we are also offering a free
digital weekly newspaper to subscribers to
the online package.
Click here for more subscription options,
including to the print version of our
flagship monthly magazine:
Take a trial to our premium daily news
service aimed at professional investors that
covers the 30 countries of emerging
For any other enquiries about our
products or corporate discounts please
contact us at
If you no longer wish to receive
Magazine annual print
Website & Archive
Combined package: web
access & magazine print
Take a trial to our premium daily news service
aimed at professional investors that
covers the 30 countries of emerging Europe: